Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kinjirushi Co., Ltd. is a Japanese pioneer in wasabi cultivation, processing, and scientific research, founded in 1929. Beyond its culinary products, the company has spent decades studying the functional properties of wasabi-derived bioactive compounds, establishing a dedicated research institute to explore their health and beauty benefits. Kinjirushi's research focuses on hexaraphane (6-MSITC), a potent antioxidant and anti-inflammatory compound found in the wasabi rhizome, which has been clinically shown to improve episodic and working memory in older adults. The company commercializes these scientific discoveries through functional ingredients and dietary supplements, such as Wasabi Sulfinyl® for cognitive health and Wasabi-flavone® for skin elasticity and hair growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kinjirushi.